Blayer CropScience Gears Up for Q3 Reveal on 11th February; Check Key Expectations Here
- February 10, 2026
- Posted by: Ekta Dhawan
- Category: News
Click and Sign Up to Get Live Updates on Q3 Results
Blayer CropScience ‘s Q3 results FY26 are scheduled to be announced on 11th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Blayer CropScience Q3 Results 2026 Preview
- Blayer CropScience’s revenue is expected to be in the range of ₹1,056.90 crore, a 39.17% YoY decrease.
- Profit After Tax, or PAT, is projected to fall 74.91% YoY.
- Net profit is ₹34.20 crore, down 74.91% YoY
- EBITDA to fall 97.29%
Blayer CropScience Share Performance
- Over the past six months, Blayer CropScience’ share price has risen by 1.05% to ₹71.22.
- Moreover, over the past year, the stock has increased by 5.05%.
- Despite this weak short-term performance, Blayer CropScience’ stock has delivered a financially sound 51.37% return over the past 5 years.
- As of 10th February 2026, the stock traded at ₹71.22 per share.
About Blayer CropScience
Bayer CropScience Ltd is a leading agriculture and life sciences company in India and a part of the global Bayer Group, headquartered in Germany. It operates in the crop science segment, providing farmers with innovative solutions such as crop protection chemicals, hybrid seeds, and digital farming services to improve productivity and sustainability. The company focuses on developing insecticides, herbicides, fungicides, and high-quality seeds that help protect crops from pests, diseases, and weeds.
Key Factors to Watch for Blayer CropScience Q3 Results FY26
- Revenue Growth & Segment Performance: Performance of crop protection and seeds business, and overall sales growth versus last year and last quarter.
- Profitability & Margins: Trends in EBITDA and net profit margins amid input cost and pricing pressures.
- Impact of Monsoon & Farm Demand: Effect of weather conditions and cropping patterns on product demand and volumes.
- Product Mix & New Launches: Contribution from high-margin products, new molecules, and hybrid seeds.
- Management Outlook & Guidance: Commentary on FY26 growth outlook, cost control, and future strategy.
Final Thoughts
Blayer CropScience will announce its Q3 FY26 results on 11th February 2026. Analysts expect 39.17% revenue growth, a 74.91% fall in PAT, and a 97.29% fall in EBITDA. Blayer CropScience focuses revenue and margin performance driven by monsoon-led demand, product mix improvement, and management’s outlook on growth and profitability.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Alfred Herbert India Ltd Q3 Results FY26 Preview: PAT falls 3%
Salora International Q3 Results FY26 Preview: PAT falls 18.54%
Kuantum Papers Q3 Results FY26 Preview: PAT falls 29.85%
AK Capital Services Ltd Q3 Results FY26 Preview: PAT falls 16.86%
